Busse WW - Search Results

1

Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.

Busse WW, Israel E, Nelson HS, Baker JW, Charous BL, Young DY, Vexler V, Shames RS; Daclizumab Asthma Study Group. Busse WW, et al. Am J Respir Crit Care Med. 2008 Nov 15;178(10):1002-8. doi: 10.1164/rccm.200708-1200OC. Epub 2008 Sep 11. Am J Respir Crit Care Med. 2008. PMID: 18787222 Clinical Trial.

2

Childhood- versus adult-onset asthma.

Busse W, Banks-Schlegel SP, Larsen GL. Busse W, et al. Am J Respir Crit Care Med. 1995 May;151(5):1635-9. doi: 10.1164/ajrccm.151.5.7735626. Am J Respir Crit Care Med. 1995. PMID: 7735626 No abstract available.

3

Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma.

Bates ME, Clayton M, Calhoun W, Jarjour N, Schrader L, Geiger K, Schultz T, Sedgwick J, Swenson C, Busse W. Bates ME, et al. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):667-72. doi: 10.1164/ajrccm.149.3.8118634. Am J Respir Crit Care Med. 1994. PMID: 8118634

4

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.

Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegel SC, Tinkelman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J, Lanni C, Pearlman H, Karahalios P, Drazen JM. Israel E, et al. Ann Intern Med. 1993 Dec 1;119(11):1059-66. doi: 10.7326/0003-4819-119-11-199312010-00001. Ann Intern Med. 1993. PMID: 8239223 Clinical Trial.

5

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Busse W, et al. J Allergy Clin Immunol. 1999 Jun;103(6):1075-80. doi: 10.1016/s0091-6749(99)70182-x. J Allergy Clin Immunol. 1999. PMID: 10359889 Clinical Trial.

6

Airway remodeling and repair.

Busse W, Elias J, Sheppard D, Banks-Schlegel S. Busse W, et al. Am J Respir Crit Care Med. 1999 Sep;160(3):1035-42. doi: 10.1164/ajrccm.160.3.9902064. Am J Respir Crit Care Med. 1999. PMID: 10471638 No abstract available.

7

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.

Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K; Fluticasone Proprionate Clinical Research Study Group. Busse W, et al. J Allergy Clin Immunol. 2001 Mar;107(3):461-8. doi: 10.1067/mai.2001.114657. J Allergy Clin Immunol. 2001. PMID: 11240946 Clinical Trial.

8

Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.

Busse W, Wolfe J, Storms W, Srebro S, Edwards L, Johnson M, Bowers BW, Rogenes PR, Rickard K. Busse W, et al. J Fam Pract. 2001 Jul;50(7):595-602. J Fam Pract. 2001. PMID: 11485708 Clinical Trial.

9

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N. Busse W, et al. J Allergy Clin Immunol. 2001 Aug;108(2):184-90. doi: 10.1067/mai.2001.117880. J Allergy Clin Immunol. 2001. PMID: 11496232 Clinical Trial.

10

Asthma.

Eapen SS, Busse WW. Eapen SS, et al. Among authors: busse ww. Clin Allergy Immunol. 2002;16:325-53. Clin Allergy Immunol. 2002. PMID: 11577547 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

593 results

Search Page

Filters